Detalles de la búsqueda
1.
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review.
Infection
; 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38602623
2.
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review.
Infection
; 52(1): 1-17, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37776474
3.
Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England.
BMC Infect Dis
; 24(1): 428, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649824
4.
Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort study.
Pulm Pharmacol Ther
; 83: 102260, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37741357
5.
Validity of Routine Health Data To Identify Safety Outcomes of Interest For Covid-19 Vaccines and Therapeutics in the Context of the Emerging Pandemic: A Comprehensive Literature Review.
Drug Healthc Patient Saf
; 16: 1-17, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38192299
6.
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry.
Drug Saf
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727875
7.
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study.
BMJ Open Respir Res
; 11(1)2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38575338
8.
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C).
Clin Drug Investig
; 44(3): 183-198, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38379107
9.
Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review.
Infect Dis Ther
; 12(1): 33-51, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36378465
10.
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USA.
Infect Dis Ther
; 12(2): 607-621, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36629998
11.
Effectiveness of Sotrovimab in Preventing COVID-19-Related Hospitalizations or Deaths Among US Veterans During Omicron BA.1.
Open Forum Infect Dis
; 10(12): ofad605, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38152625
Resultados
1 -
11
de 11
1
Próxima >
>>